Houston, TX, United States of America

E Edmund Kim

This inventor holds 11 USPTO granted patents and 4 published patent applications, plus 2 CIPO patents and 2 EPO patents. Top assignees: The University of Texas System, Massachusetts Institute of Technology. Active years: 2004-2013.

IDiyas Innovation Intelligence. (2026). Inventor Profile: E Edmund Kim. Retrieved from https://idiyas.com/inventor/e-edmund-kim

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 11 

% Patents Active = 54.5


 

Average Co-Inventor Count = 4.4

ph-index = 5

Forward Citations = 176(Granted Patents)


Location History:

  • Houson, TX (US) (2012)
  • Houston, TX (US) (2004 - 2013)

Company Filing History:


Years Active: 2004-2013

Loading Chart...
Loading Chart...
Loading Chart...
11 patents (USPTO):Explore Patents

Title: E Edmund Kim: Innovator in Cardiovascular Imaging and Treatment

Introduction

E Edmund Kim is a prominent inventor based in Houston, TX (US), known for his significant contributions to the field of cardiovascular imaging and treatment. With a total of 11 patents to his name, Kim has developed innovative solutions that enhance the diagnosis and treatment of myocardial diseases.

Latest Patents

Among his latest patents, Kim has introduced groundbreaking technologies such as "Image-guided therapy of myocardial disease: composition, manufacturing and applications." This invention discloses compositions and methods for imaging, chemotherapy, and radiotherapy, focusing on agents that comprise a targeting moiety with a beta-adrenergic receptor targeting compound conjugated or embedded with ethylenediamine. The invention also details methods for applying these agents in the imaging and treatment of cardiovascular diseases, along with kits for preparing radiolabeled therapeutic or diagnostic agents. Another notable patent is "Bisaminoethanethiol-targeting ligand conjugates and compositions," which presents a new labeling strategy using technetium (Tc) chelated with ethylenedicysteine (EC). This innovation allows for the conjugation of EC with various ligands, making it a valuable imaging agent for tissue-specific diseases.

Career Highlights

E Edmund Kim has had a distinguished career, working with esteemed institutions such as the University of Texas System and the Massachusetts Institute of Technology. His work has significantly advanced the field of medical imaging and therapeutic delivery systems.

Collaborations

Throughout his career, Kim has collaborated with notable professionals, including David J Yang and Dong-Fang Yu, contributing to the development of innovative solutions in his field.

Conclusion

E Edmund Kim's contributions to cardiovascular imaging and treatment exemplify the impact of innovation in healthcare. His patents and collaborations continue to pave the way for advancements in medical technology.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…